We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Assisted Blood-Glucose Monitoring Causes Hepatitis B Outbreaks

By HospiMedica International staff writers
Posted on 09 Jul 2012
A new study reveals that Hepatitis B Virus (HBV) infections were related to assisted monitoring of blood glucose (AMBG) among residents of assisted living facilities (ALFs).

Researchers at the Virginia Department of Health (VDH; Richmond, USA) examined acute HBV infections that occurred in residents of four separate ALFs in the Central Health Planning Region of Virginia (USA) that occurred between February 2009 and November 2011; in each outbreak, the initial acute HBV infections were identified through routine viral hepatitis surveillance. More...
As a result, the VDH conducted epidemiologic and laboratory investigations of these reports and assessed infection control practices, particularly surrounding AMBG, by direct observation and staff member interviews.

The investigation and subsequent screening of ALF residents for HBV uncovered additional acute HBV infections at each of the ALFs. All acute HBV infections were among residents receiving AMBG for management of diabetes. The researchers identified lapses in infection prevention practices during AMBG at three of the four facilities, a procedure routinely delivered on-site by various unlicensed or licensed personnel, including medication aides, nurses, and others. The study was published in the May 18, 2012, issue of the Morbidity and Mortality Weekly Report (MMWR), published by the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).

“These outbreaks highlight the role of hepatitis B surveillance in detecting disease outbreaks and the need for a comprehensive strategy to prevent HBV transmission in ALFs, including vaccination, improved infection control oversight at ALFs, appropriate training of staff members performing AMBG, and prompt investigation of acute HBV infections,” concluded lead author Yeatoe McIntosh, MPH, and colleagues.

The researchers recommended vaccination of adults with diabetes in this age group, based on the patient's diminished likelihood of responding to vaccine and the likelihood of acquiring HBV infection, including the risk posed by an increased need for AMBG in long-term–care facilities. Vaccination alone, however, is unlikely to completely eliminate HBV transmission risk in ALFs; in addition to HBV vaccination, the researchers recommend other interventions, including improving infection control oversight at ALFs, training staff members to appropriately perform AMBG, and ensuring that each ALF has a sufficient number of trained personnel to perform AMBG 7 days per week.

Related Links:

Virginia Department of Health
US Centers for Disease Control and Prevention



New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Multi-Chamber Washer-Disinfector
WD 390
New
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Six-month FlexPulse IDE data show positive outcomes with Abbott’s TactiFlex Duo catheter, confirming safety and efficacy seen in the CE Mark study for complex AFib (photo courtesy of Abbott)

Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes

Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.